-
CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to "Sell" Rating
来源: Buzz FX / 21 3月 2025 01:21:18 America/Chicago
CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to "Sell" Rating Written by MarketBeat March 21, 2025 Share Link copied to clipboard. Remove Ads CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) was upgraded by StockNews.com
Read more...